rs1965024

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002968.3(SALL1):​c.2574C>T​(p.Leu858Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.638 in 1,613,246 control chromosomes in the GnomAD database, including 338,355 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 23760 hom., cov: 33)
Exomes 𝑓: 0.65 ( 314595 hom. )

Consequence

SALL1
NM_002968.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -2.39

Publications

32 publications found
Variant links:
Genes affected
SALL1 (HGNC:10524): (spalt like transcription factor 1) The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SALL1 Gene-Disease associations (from GenCC):
  • Townes-Brocks syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Townes-Brocks syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 16-51139648-G-A is Benign according to our data. Variant chr16-51139648-G-A is described in ClinVar as Benign. ClinVar VariationId is 258866.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.39 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SALL1NM_002968.3 linkc.2574C>T p.Leu858Leu synonymous_variant Exon 2 of 3 ENST00000251020.9 NP_002959.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SALL1ENST00000251020.9 linkc.2574C>T p.Leu858Leu synonymous_variant Exon 2 of 3 1 NM_002968.3 ENSP00000251020.4

Frequencies

GnomAD3 genomes
AF:
0.518
AC:
78718
AN:
151988
Hom.:
23755
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.646
Gnomad AMR
AF:
0.606
Gnomad ASJ
AF:
0.526
Gnomad EAS
AF:
0.713
Gnomad SAS
AF:
0.735
Gnomad FIN
AF:
0.618
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.653
Gnomad OTH
AF:
0.532
GnomAD2 exomes
AF:
0.626
AC:
157353
AN:
251370
AF XY:
0.638
show subpopulations
Gnomad AFR exome
AF:
0.172
Gnomad AMR exome
AF:
0.653
Gnomad ASJ exome
AF:
0.522
Gnomad EAS exome
AF:
0.708
Gnomad FIN exome
AF:
0.632
Gnomad NFE exome
AF:
0.649
Gnomad OTH exome
AF:
0.623
GnomAD4 exome
AF:
0.650
AC:
950250
AN:
1461140
Hom.:
314595
Cov.:
75
AF XY:
0.654
AC XY:
475254
AN XY:
726798
show subpopulations
African (AFR)
AF:
0.165
AC:
5519
AN:
33436
American (AMR)
AF:
0.649
AC:
28988
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
13602
AN:
26128
East Asian (EAS)
AF:
0.728
AC:
28891
AN:
39684
South Asian (SAS)
AF:
0.733
AC:
63199
AN:
86252
European-Finnish (FIN)
AF:
0.635
AC:
33928
AN:
53416
Middle Eastern (MID)
AF:
0.477
AC:
2747
AN:
5760
European-Non Finnish (NFE)
AF:
0.662
AC:
735423
AN:
1111386
Other (OTH)
AF:
0.629
AC:
37953
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
20969
41938
62906
83875
104844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19046
38092
57138
76184
95230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.518
AC:
78721
AN:
152106
Hom.:
23760
Cov.:
33
AF XY:
0.523
AC XY:
38875
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.183
AC:
7603
AN:
41502
American (AMR)
AF:
0.607
AC:
9276
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.526
AC:
1828
AN:
3472
East Asian (EAS)
AF:
0.714
AC:
3683
AN:
5156
South Asian (SAS)
AF:
0.735
AC:
3533
AN:
4808
European-Finnish (FIN)
AF:
0.618
AC:
6544
AN:
10592
Middle Eastern (MID)
AF:
0.490
AC:
144
AN:
294
European-Non Finnish (NFE)
AF:
0.653
AC:
44402
AN:
67972
Other (OTH)
AF:
0.532
AC:
1123
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1648
3296
4945
6593
8241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.577
Hom.:
17048
Bravo
AF:
0.501
Asia WGS
AF:
0.698
AC:
2424
AN:
3478
EpiCase
AF:
0.640
EpiControl
AF:
0.638

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Townes-Brocks syndrome 1 Benign:4
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 21, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Nov 24, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Townes syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.047
DANN
Benign
0.49
PhyloP100
-2.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1965024; hg19: chr16-51173559; COSMIC: COSV51760559; COSMIC: COSV51760559; API